DEERFIELD CAPITAL LP

10% owner at PAR PHARMACEUTICAL COMPANIES, INC. · on record since Feb 1, 2007
10% owner at DA32 Life Science Tech Acquisition Corp. · on record since Aug 1, 2023
Director by Deputization at DA32 Life Science Tech Acquisition Corp. · on record since Aug 1, 2023
10% owner at Larimar Therapeutics, Inc. · on record since Feb 16, 2024
* Director by Deputization at Larimar Therapeutics, Inc. · on record since Feb 16, 2024
10% owner at AdaptHealth Corp. · on record since Mar 12, 2024
*Possible Member of 10% Group at AdaptHealth Corp. · on record since Mar 12, 2024
10% owner at Bicara Therapeutics Inc. · on record since Sep 17, 2024
*Possible Member of 10% Group at Bicara Therapeutics Inc. · on record since Sep 12, 2024
10% owner at Nuvalent, Inc. · on record since Oct 24, 2024
10% owner at INSPIRE PHARMACEUTICALS INC · on record since May 2, 2007
10% owner at VIA Pharmaceuticals, Inc. · on record since Aug 24, 2007
10% owner at DYNAVAX TECHNOLOGIES CORP · on record since Jul 23, 2007
10% owner at DUSA PHARMACEUTICALS INC · on record since Nov 27, 2007
10% owner at EMAGEON INC · on record since Nov 27, 2007
10% owner at ANADYS PHARMACEUTICALS INC · on record since Oct 25, 2007
10% owner at ARENA PHARMACEUTICALS INC · on record since Oct 23, 2007
10% owner at NeurogesX Inc · on record since Mar 31, 2008
10% owner at · on record since Mar 14, 2008
Director by Deputization at · on record since Oct 24, 2024
10% owner at · on record since May 6, 2008
10% owner at · on record since Oct 21, 2008
10% owner at · on record since Dec 5, 2008
10% owner at · on record since Jun 19, 2009
10% owner at · on record since Aug 17, 2004
Director at · on record since Apr 4, 2018
10% owner at · on record since Dec 27, 2018
Director at · on record since Mar 17, 2020
Director at · on record since Jul 22, 2020
Director at · on record since Aug 12, 2020
Director at · on record since Oct 8, 2020
Director at · on record since Jul 27, 2021
Director at · on record since Sep 20, 2022
Director at · on record since Nov 7, 2022

Insider trading activity of DEERFIELD CAPITAL LP

Transactions on record: 259; since Feb 24, 2006

Open-market buys: 98; $174.8M

Open-market sells: 119; $247.9M

Companies traded: 32; last filing Oct 24, 2024

Figures computed from official regulatory filings — .

Companies where DEERFIELD CAPITAL LP has traded

3 tx · $217.3M · Oct 24, 2024
12 tx · $39.1M · Feb 16, 2024
6 tx · $12.4M · Oct 28, 2021
1 tx · Aug 9, 2021
1 tx · $33.6M · Jul 22, 2020
7 tx · $15.6M · Dec 23, 2019
5 tx · $4M · Oct 7, 2019
2 tx · $7.7K · Jun 26, 2019
11 tx · $510K · Mar 11, 2019
6 tx · $16M · May 31, 2018
10 tx · $2.2M · Mar 21, 2018
6 tx · $6M · Oct 10, 2017
2 tx · $444K · Jun 9, 2017
3 tx · $1.1M · Dec 14, 2016

Track record of DEERFIELD CAPITAL LP

Statistical track record

Free account

Open-market buys: 100

Last buy: Feb 16, 2024

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of DEERFIELD CAPITAL LP

Co-insiders of DEERFIELD CAPITAL LP

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Nuvalent, Inc.Security delisted	Oct 24, 2024	Sell	-1,000,000	97.75 USD	$97.8M	Unusual size	SEC
Nuvalent, Inc.Security delisted	Oct 24, 2024	Sell	-1,000,000	97.75 USD	$97.8M	Unusual size	SEC
Larimar Therapeutics, Inc.Listing on record	Feb 16, 2024	Buy	1,430,206	8.74 USD	$12.5M	conv 61ClusterFirst in 12mo	SEC
Larimar Therapeutics, Inc.Listing on record	Feb 16, 2024	Buy	1,430,206	8.74 USD	$12.5M	conv 61ClusterFirst in 12mo	SEC
Larimar Therapeutics, Inc.Listing on record	Feb 16, 2024	Buy	1,430,205	8.74 USD	$12.5M	conv 66ClusterFirst in 12mo	SEC
Nuvalent, Inc.Security delisted	Nov 7, 2022	Buy	650,000	33.50 USD	$21.8M	conv 68Unusual sizeFirst in 12mo	SEC
Xilio Therapeutics, Inc.Listing on record	Oct 28, 2021	Other	756,472	—	n/a (No price was disclosed in the filing)		SEC
Xilio Therapeutics, Inc.Listing on record	Oct 28, 2021	Other	756,472	—	n/a (No price was disclosed in the filing)		SEC
Xilio Therapeutics, Inc.Listing on record	Oct 28, 2021	OtherD (derivative)	-7,186,489	—	n/a (No price was disclosed in the filing)		SEC
Xilio Therapeutics, Inc.Listing on record	Oct 28, 2021	Buy	387,500	16.00 USD	$6.2M	conv 67ClusterFirst in 12mo	SEC
Xilio Therapeutics, Inc.Listing on record	Oct 28, 2021	Buy	387,500	16.00 USD	$6.2M	conv 67ClusterFirst in 12mo	SEC
Xilio Therapeutics, Inc.Listing on record	Oct 28, 2021	OtherD (derivative)	-7,186,489	—	n/a (No price was disclosed in the filing)		SEC
DA32 Life Science Tech Acquisition Corp.Listing unverified	Aug 9, 2021	OtherD (derivative)	-701,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CareMax, Inc.Listing unverified	Jul 22, 2020	Other	3,360,000	10.00 USD	$33.6M	Unusual size	SEC
Q32 Bio Inc.Listing on record	Dec 23, 2019	Sell	-56,595	21.83 USD	$1.2M	Unusual size	SEC
Q32 Bio Inc.Listing on record	Dec 23, 2019	Sell	-7,168	21.68 USD	$155.4K		SEC
Q32 Bio Inc.Listing on record	Dec 23, 2019	Sell	-5,454	21.68 USD	$118.2K		SEC
Q32 Bio Inc.Listing on record	Dec 23, 2019	Sell	-11,999	21.50 USD	$258K		SEC
Q32 Bio Inc.Listing on record	Dec 23, 2019	Sell	-9,130	21.50 USD	$196.3K		SEC
Q32 Bio Inc.Listing on record	Dec 23, 2019	Sell	-74,384	21.83 USD	$1.6M	Unusual size	SEC
Korro Bio, Inc.Listing on record	Oct 7, 2019	OtherD (derivative)	-3,184,948	—	n/a (No price was disclosed in the filing)		SEC
Korro Bio, Inc.Listing on record	Oct 7, 2019	Other	472,860	—	n/a (No price was disclosed in the filing)		SEC
Korro Bio, Inc.Listing on record	Oct 7, 2019	Buy	285,714	14.00 USD	$4M	conv 50Cluster	SEC
Korro Bio, Inc.Listing on record	Oct 7, 2019	OtherD (derivative)	-3,184,948	—	n/a (No price was disclosed in the filing)		SEC
Korro Bio, Inc.Listing on record	Oct 7, 2019	Other	472,860	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Nuvalent, Inc.Security delisted	Oct 24, 2024	Sell	-1,000,000	97.75 USD	$97.8M	Unusual size	SEC
Nuvalent, Inc.Security delisted	Oct 24, 2024	Sell	-1,000,000	97.75 USD	$97.8M	Unusual size	SEC
Larimar Therapeutics, Inc.Listing on record	Feb 16, 2024	Buy	1,430,206	8.74 USD	$12.5M	conv 61ClusterFirst in 12mo	SEC
Larimar Therapeutics, Inc.Listing on record	Feb 16, 2024	Buy	1,430,206	8.74 USD	$12.5M	conv 61ClusterFirst in 12mo	SEC
Larimar Therapeutics, Inc.Listing on record	Feb 16, 2024	Buy	1,430,205	8.74 USD	$12.5M	conv 66ClusterFirst in 12mo	SEC
Nuvalent, Inc.Security delisted	Nov 7, 2022	Buy	650,000	33.50 USD	$21.8M	conv 68Unusual sizeFirst in 12mo	SEC
Xilio Therapeutics, Inc.Listing on record	Oct 28, 2021	Other	756,472	—	n/a (No price was disclosed in the filing)		SEC
Xilio Therapeutics, Inc.Listing on record	Oct 28, 2021	Other	756,472	—	n/a (No price was disclosed in the filing)		SEC
Xilio Therapeutics, Inc.Listing on record	Oct 28, 2021	OtherD (derivative)	-7,186,489	—	n/a (No price was disclosed in the filing)		SEC
Xilio Therapeutics, Inc.Listing on record	Oct 28, 2021	Buy	387,500	16.00 USD	$6.2M	conv 67ClusterFirst in 12mo	SEC
Xilio Therapeutics, Inc.Listing on record	Oct 28, 2021	Buy	387,500	16.00 USD	$6.2M	conv 67ClusterFirst in 12mo	SEC
Xilio Therapeutics, Inc.Listing on record	Oct 28, 2021	OtherD (derivative)	-7,186,489	—	n/a (No price was disclosed in the filing)		SEC
DA32 Life Science Tech Acquisition Corp.Listing unverified	Aug 9, 2021	OtherD (derivative)	-701,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CareMax, Inc.Listing unverified	Jul 22, 2020	Other	3,360,000	10.00 USD	$33.6M	Unusual size	SEC
Q32 Bio Inc.Listing on record	Dec 23, 2019	Sell	-56,595	21.83 USD	$1.2M	Unusual size	SEC
Q32 Bio Inc.Listing on record	Dec 23, 2019	Sell	-7,168	21.68 USD	$155.4K		SEC
Q32 Bio Inc.Listing on record	Dec 23, 2019	Sell	-5,454	21.68 USD	$118.2K		SEC
Q32 Bio Inc.Listing on record	Dec 23, 2019	Sell	-11,999	21.50 USD	$258K		SEC
Q32 Bio Inc.Listing on record	Dec 23, 2019	Sell	-9,130	21.50 USD	$196.3K		SEC
Q32 Bio Inc.Listing on record	Dec 23, 2019	Sell	-74,384	21.83 USD	$1.6M	Unusual size	SEC
Korro Bio, Inc.Listing on record	Oct 7, 2019	OtherD (derivative)	-3,184,948	—	n/a (No price was disclosed in the filing)		SEC
Korro Bio, Inc.Listing on record	Oct 7, 2019	Other	472,860	—	n/a (No price was disclosed in the filing)		SEC
Korro Bio, Inc.Listing on record	Oct 7, 2019	Buy	285,714	14.00 USD	$4M	conv 50Cluster	SEC
Korro Bio, Inc.Listing on record	Oct 7, 2019	OtherD (derivative)	-3,184,948	—	n/a (No price was disclosed in the filing)		SEC
Korro Bio, Inc.Listing on record	Oct 7, 2019	Other	472,860	—	n/a (No price was disclosed in the filing)		SEC